Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells-Reference-Cited by-同舟云学术

Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells

Published:2003-08 Issue:17 Volume:10 Page:1512-1518
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Hillman G G,Kallinteris N L,Li J,Wang Y,Lu X,Li Y,Wu S,Wright J L,Slos P,Gulfo J V,Humphreys R E,Xu M

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3302027.pdf

Reference30 articles.

1. Pardoll DM, Topalian SL . The role of CD4+ T cell responses in antitumor immunity. Curr Opin Immunol 1998; 10: 588–594.

2. Wang RF . The role of MHC Class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends Immunol 2001; 22: 269–276.

3. Ostrand-Rosenberg S et al. Cell-based vaccines for the stimulation of immunity to metastatic cancers. Immunol Rev 1999; 170: 101–114.

4. Clements VK, Baskar S, Armstrong TD, Ostrand-Rosenberg S . Invariant chain alters the malignant phenotype of MHC Class II+ tumor cells. J Immunol 1992; 149: 2391–2396.

5. Armstrong TD et al. Major histocompatibility complex Class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc Natl Acad Sci USA 1997; 94: 6886–6891.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement;Biomolecules;2020-02-17

2. Expression of CD74 in Invasive Breast Carcinoma: Its Relation to Nottingham Prognostic Index, Hormone Receptors, and HER2 Immunoprofile;Tumori Journal;2016-02-11

3. Tumor Cell Transformation Using Antisense Oligonucleotide;Methods in Molecular Biology;2014

4. Experimental Animal Models for Investigating Renal Cell Carcinoma Pathogenesis and Preclinical Therapeutic Approaches;Tumor Models in Cancer Research;2010-11-20

5. Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells;Cellular Immunology;2007-09